GB0509226D0 - Enzyme and receptor modulation - Google Patents

Enzyme and receptor modulation

Info

Publication number
GB0509226D0
GB0509226D0 GB0509226A GB0509226A GB0509226D0 GB 0509226 D0 GB0509226 D0 GB 0509226D0 GB 0509226 A GB0509226 A GB 0509226A GB 0509226 A GB0509226 A GB 0509226A GB 0509226 D0 GB0509226 D0 GB 0509226D0
Authority
GB
United Kingdom
Prior art keywords
enzyme
receptor modulation
receptor
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0509226A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chroma Therapeutics Ltd
Original Assignee
Chroma Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chroma Therapeutics Ltd filed Critical Chroma Therapeutics Ltd
Priority to GB0509226A priority Critical patent/GB0509226D0/en
Publication of GB0509226D0 publication Critical patent/GB0509226D0/en
Priority to CA2836827A priority patent/CA2836827C/en
Priority to AU2006243000A priority patent/AU2006243000B2/en
Priority to PT06727008T priority patent/PT1877098E/pt
Priority to NZ561710A priority patent/NZ561710A/en
Priority to CA2607020A priority patent/CA2607020C/en
Priority to ES06727008T priority patent/ES2415244T3/es
Priority to PCT/GB2006/001635 priority patent/WO2006117567A2/en
Priority to EP06727008.2A priority patent/EP1877098B1/en
Priority to SI200631620T priority patent/SI1877098T1/sl
Priority to DK06727008.2T priority patent/DK1877098T3/da
Priority to CN200680014981.9A priority patent/CN101171039B/zh
Priority to BRPI0610368A priority patent/BRPI0610368A8/pt
Priority to US11/918,138 priority patent/US20090215800A1/en
Priority to KR1020077023742A priority patent/KR101332904B1/ko
Priority to JP2008509506A priority patent/JP2008542196A/ja
Priority to MX2007013257A priority patent/MX2007013257A/es
Priority to EP20080075301 priority patent/EP1964578A3/en
Priority to ES08075300.7T priority patent/ES2577433T3/es
Priority to SG2014007512A priority patent/SG2014007512A/en
Priority to EP19156158.8A priority patent/EP3530290A1/en
Priority to PL06727008T priority patent/PL1877098T3/pl
Priority to EP08075300.7A priority patent/EP1964577B1/en
Priority to IL186091A priority patent/IL186091A0/en
Priority to ZA200708283A priority patent/ZA200708283B/xx
Priority to JP2013139093A priority patent/JP2013241423A/ja
Priority to CY20131100626T priority patent/CY1114224T1/el
Priority to US14/508,248 priority patent/US20150126534A1/en
Priority to US15/650,031 priority patent/US20180000952A1/en
Priority to US16/255,947 priority patent/US20190231887A1/en
Priority to US17/326,470 priority patent/US20210361772A1/en
Ceased legal-status Critical Current

Links

GB0509226A 2005-05-05 2005-05-05 Enzyme and receptor modulation Ceased GB0509226D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB0509226A GB0509226D0 (en) 2005-05-05 2005-05-05 Enzyme and receptor modulation
BRPI0610368A BRPI0610368A8 (pt) 2005-05-05 2006-05-04 Modulação de enzima e de receptor
KR1020077023742A KR101332904B1 (ko) 2005-05-05 2006-05-04 효소 및 수용체 조작
EP20080075301 EP1964578A3 (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
JP2008509506A JP2008542196A (ja) 2005-05-05 2006-05-04 カルボキシルエステラーゼにより加水分解可能なアルファアミノ酸エステル−薬剤複合体
NZ561710A NZ561710A (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
CA2607020A CA2607020C (en) 2005-05-05 2006-05-04 Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases
ES06727008T ES2415244T3 (es) 2005-05-05 2006-05-04 Conjugados de éster de aminoácido alfa-fármaco hidrolizables mediante carboxilesterasa
PCT/GB2006/001635 WO2006117567A2 (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
EP06727008.2A EP1877098B1 (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
SI200631620T SI1877098T1 (sl) 2005-05-05 2006-05-04 S karboksilesterazo hidrolizabilen zdravilen konjugat estra alfa aminokisline
DK06727008.2T DK1877098T3 (da) 2005-05-05 2006-05-04 Alpha-aminosyreester-lægemiddelkonjugater, der kan hydrolyseres ved hjælp af carboxylesterase
CN200680014981.9A CN101171039B (zh) 2005-05-05 2006-05-04 酶和受体调节
AU2006243000A AU2006243000B2 (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
US11/918,138 US20090215800A1 (en) 2005-05-05 2006-05-04 Enzyme and Receptor Modulation
CA2836827A CA2836827C (en) 2005-05-05 2006-05-04 Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases
PT06727008T PT1877098E (pt) 2005-05-05 2006-05-04 Conjugados éster de alfa aminoácido - fármaco hidrolisáveis por carboxilesterase
MX2007013257A MX2007013257A (es) 2005-05-05 2006-05-04 Conjugados de ester de alfa-aminoacido-farmaco hidrolizables por carboxilesterasa.
EP08075300.7A EP1964577B1 (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
ES08075300.7T ES2577433T3 (es) 2005-05-05 2006-05-04 Conjugados éster de alfa aminoácido-fármaco hidrolizables por la carboxilesterasa
SG2014007512A SG2014007512A (en) 2005-05-05 2006-05-04 Enzyme and receptor modulation
EP19156158.8A EP3530290A1 (en) 2005-05-05 2006-05-04 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
PL06727008T PL1877098T3 (pl) 2005-05-05 2006-05-04 Koniugaty estru alfa-aminokwasu z lekiem ulegające hydrolizie z udziałem karboksyloesterazy
IL186091A IL186091A0 (en) 2005-05-05 2007-09-20 Enzyme and receptor modulation
ZA200708283A ZA200708283B (en) 2005-05-05 2007-09-27 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
JP2013139093A JP2013241423A (ja) 2005-05-05 2013-07-02 カルボキシルエステラーゼにより加水分解可能なアルファアミノ酸エステル−薬剤複合体
CY20131100626T CY1114224T1 (el) 2005-05-05 2013-07-23 Συζευγματα εστερα αλφα αμινοξεως-φαρμακου υδρολυομενα απο καρβοξυλεστεραση
US14/508,248 US20150126534A1 (en) 2005-05-05 2014-10-07 Enzyme and receptor modulation
US15/650,031 US20180000952A1 (en) 2005-05-05 2017-07-14 Enzyme and receptor modulation
US16/255,947 US20190231887A1 (en) 2005-05-05 2019-01-24 Enzyme and receptor modulation
US17/326,470 US20210361772A1 (en) 2005-05-05 2021-05-21 Enzyme and receptor modulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0509226A GB0509226D0 (en) 2005-05-05 2005-05-05 Enzyme and receptor modulation

Publications (1)

Publication Number Publication Date
GB0509226D0 true GB0509226D0 (en) 2005-06-15

Family

ID=34685158

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0509226A Ceased GB0509226D0 (en) 2005-05-05 2005-05-05 Enzyme and receptor modulation

Country Status (10)

Country Link
CN (1) CN101171039B (pt)
CA (1) CA2836827C (pt)
DK (1) DK1877098T3 (pt)
ES (2) ES2415244T3 (pt)
GB (1) GB0509226D0 (pt)
NZ (1) NZ561710A (pt)
PT (1) PT1877098E (pt)
SG (1) SG2014007512A (pt)
SI (1) SI1877098T1 (pt)
ZA (1) ZA200708283B (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1231919B1 (en) * 1999-09-08 2015-09-30 Sloan-Kettering Institute For Cancer Research Derivatives of 1-amino-1-(hetero)arylaminocarbonyl-6-hydroxyaminocarbonylhexane useful in the treatment of tumors
WO2005037272A1 (en) * 2003-10-22 2005-04-28 Arpida A/S Benzimidazole derivatives and use thereof as peptide deformylase inhibitors

Also Published As

Publication number Publication date
ZA200708283B (en) 2008-10-29
ES2577433T3 (es) 2016-07-14
NZ561710A (en) 2010-08-27
PT1877098E (pt) 2013-07-31
CA2836827A1 (en) 2006-11-09
CN101171039B (zh) 2013-01-23
SI1877098T1 (sl) 2013-08-30
CN101171039A (zh) 2008-04-30
SG2014007512A (en) 2014-03-28
CA2836827C (en) 2016-05-03
DK1877098T3 (da) 2013-07-08
ES2415244T3 (es) 2013-07-24

Similar Documents

Publication Publication Date Title
IL186091A0 (en) Enzyme and receptor modulation
GB0422052D0 (en) Enzymes
AU2006339063A8 (en) Macro-diacrylates and macro-polyacrylates
EP1969123A4 (en) NEW ENZYMES
GB0522477D0 (en) Modulator
EP1910736A4 (en) BANDWIDTH SAFE LIGHTING OPTICS FOR BACK AND FRONT LUMINAIRES
IL183867A0 (en) Modulated amplifier
IL187692A0 (en) Alkylquinoline and alkylquinazoline kinase modulators
EP1859035A4 (en) IMMOBILIZED ENZYMES
EP1751115A4 (en) THERAMUTEINMODULATOREN
IL190988A0 (en) Novel highly functional enzyme having modified substrate-specificity
IL207537A0 (en) Enzyme and receptor modulation
GB2446908B (en) Structure and connection member for structure
GB2418439B (en) Rock-bit and rock-bit seal
MX296535B (es) Enzima laccasa novedosa y uso de la misma.
ZA200804302B (en) 3-amlno-1-arylpropyl indoles and aza-substituted indoles
IL188314A0 (en) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
GB0516699D0 (en) Novel peroxidases and uses
EP1965829A4 (en) ALTERNATIVE OXIDASE AND ITS USES
SG2014007512A (en) Enzyme and receptor modulation
GB0505620D0 (en) Methods and materials therefor
GB2422232B (en) Course and sail-plan predictor
ZA200800272B (en) Alkylquinoline and alkylquinazoline kinase modulators
GB0419595D0 (en) Enzyme
GB0423688D0 (en) Enzyme

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)